Back
Corporate News
Bafna Pharmaceuticals to review financial results at board meeting on November 11, 2026
06-Nov-2026, 04:41
BAFNA PHARMACEUTICALS LIMITED will hold a board meeting on Wednesday, November 11, 2026, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The trading window for designated persons and their immediate relatives will be closed from October 1, 2026, to November 13, 2026, inclusive, for this purpose.
